Akebia Therapeutics, Inc. Reports annual revenue of $194.6 million
Company Records $51.9 million loss
By USInMinutes
Published - Mar 15, 2024, 07:23 AM ET
Last Updated - Mar 15, 2024, 07:23 AM EDT
Akebia Therapeutics, Inc. [AKBA] has reported $194.6 million in revenue for year ended Dec 31, 2023.
Also Read:
